Literature DB >> 14574333

High incidence and unique features of antigen receptor gene rearrangements in TEL-AML1-positive leukemias.

S Hübner1, G Cazzaniga, T Flohr, V H J van der Velden, M Konrad, U Pötschger, G Basso, M Schrappe, J J M van Dongen, C R Bartram, A Biondi, E R Panzer-Grümayer.   

Abstract

The t(12;21) translocation resulting in the TEL-AML1 gene fusion is found in 25% of childhood B-cell precursor (BCP) acute lymphoblastic leukemias (ALL). Since TEL-AML1 has been reported to induce cell cycle retardation and thus may influence somatic recombination, we analyzed 214 TEL-AML1-positive ALL by PCR for rearrangements of the immunoglobulin (Ig) and T-cell receptor (TCR) genes. As a control group, 174 childhood BCP ALL without a TEL-AML1 were used. The majority of TEL-AML1-positive leukemias had a higher number of Ig/TCR rearrangements than control ALL. They also had a more mature immunogenotype characterized by their high frequency of complete IGH, IGK-Kde, and TCRG rearrangements. While IGK-Kde and TCRG were more frequently rearranged on both alleles at higher age, IGH and TCRD rearrangements decreased in their incidence along with a decrease in biallelic IGH rearrangements. This suggests that the recombination process continues in these leukemias leading to ongoing rearrangements and possibly also deletions of antigen receptor genes. We here provide first evidence that somatic recombination of antigen receptor genes is affected by the TEL-AML1 fusion, and that further age-related differences are probably caused by the longer latency period of the prenatally initiated TEL-AML1-positive leukemias in older children.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14574333     DOI: 10.1038/sj.leu.2403182

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  7 in total

1.  RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia.

Authors:  Elli Papaemmanuil; Inmaculada Rapado; Yilong Li; Nicola E Potter; David C Wedge; Jose Tubio; Ludmil B Alexandrov; Peter Van Loo; Susanna L Cooke; John Marshall; Inigo Martincorena; Jonathan Hinton; Gunes Gundem; Frederik W van Delft; Serena Nik-Zainal; David R Jones; Manasa Ramakrishna; Ian Titley; Lucy Stebbings; Catherine Leroy; Andrew Menzies; John Gamble; Ben Robinson; Laura Mudie; Keiran Raine; Sarah O'Meara; Jon W Teague; Adam P Butler; Giovanni Cazzaniga; Andrea Biondi; Jan Zuna; Helena Kempski; Markus Muschen; Anthony M Ford; Michael R Stratton; Mel Greaves; Peter J Campbell
Journal:  Nat Genet       Date:  2014-01-12       Impact factor: 38.330

2.  Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.

Authors:  D Alpar; D Wren; L Ermini; M B Mansur; F W van Delft; C M Bateman; I Titley; L Kearney; T Szczepanski; D Gonzalez; A M Ford; N E Potter; M Greaves
Journal:  Leukemia       Date:  2014-11-12       Impact factor: 11.528

3.  Immunoglobulin Heavy Chain High-Throughput Sequencing in Pediatric B-Precursor Acute Lymphoblastic Leukemia: Is the Clonality of the Disease at Diagnosis Related to Its Prognosis?

Authors:  Gabriel Levy; Michal Kicinski; Jona Van der Straeten; Anne Uyttebroeck; Alina Ferster; Barbara De Moerloose; Marie-Francoise Dresse; Christophe Chantrain; Bénédicte Brichard; Marleen Bakkus
Journal:  Front Pediatr       Date:  2022-05-30       Impact factor: 3.569

Review 4.  Emerging functions of DNA transposases and oncogenic mutators in childhood cancer development.

Authors:  Anton G Henssen; Alex Kentsis
Journal:  JCI Insight       Date:  2018-10-18

5.  Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice.

Authors:  Eva Bauer; Michaela Schlederer; Ruth Scheicher; Jaqueline Horvath; Petra Aigner; Ana-Iris Schiefer; Renate Kain; Heinz Regele; Gregor Hoermann; Günter Steiner; Lukas Kenner; Veronika Sexl; Andreas Villunger; Richard Moriggl; Dagmar Stoiber
Journal:  Oncotarget       Date:  2016-03-15

Review 6.  In Utero Development and Immunosurveillance of B Cell Acute Lymphoblastic Leukemia.

Authors:  Nadine Rüchel; Vera H Jepsen; Daniel Hein; Ute Fischer; Arndt Borkhardt; Katharina L Gössling
Journal:  Curr Treat Options Oncol       Date:  2022-03-16

Review 7.  Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells.

Authors:  Michaela Kotrova; Nikos Darzentas; Christiane Pott; Claudia D Baldus; Monika Brüggemann
Journal:  Genes (Basel)       Date:  2021-06-27       Impact factor: 4.096

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.